Role of Fungi and Mycology in Addressing Major Global Challenge.

 

Fungi play an important in addressing major global challenge. Use of fungal processes and products can lead to increased sustainability through more efficient use of natural resource .Applications range from upgrading bio-waste for value added products to use of renewable plant biomass as a substitute for oil-based products such as bio chemicals, plastics fertilizer, and fuel. Fungal enzymes can lead to production of food ingredients with prebiotic effects for a healthier human gut biota and hence greater resilience towards life-styles diseases. Similarly, use of fungi can be a short cut to healthier animal feed and less use of antibiotics in, for example, meat production, one of the current prime sources multiple drug resistant bacteria. Fungi can be one of nature’s most promising hotspots for finding new drug candidates and antimicrobials. Then, fungi have interesting potential as the new way of manufacturing biological medicines and a wide spectrum of new value added bio-based products. Mycology must grow fast beyond where it is today. The potential of fungi for a more sustainable world must be released to address global challenges of climate change, higher demands on natural resources, and the increased burden of life- cycles diseases. Genome sequencing was developed first for the human genome after which bacterial genome were quickly sequenced. But mycology is catching up. Interestingly, up to now industry, industry makes use only for a minute portion of the fungal kingdom. Fungal biodiversity is a resource pool for the future. All such uses of fungi, fungal products process reflect the efforts of mycologist over generations. Similar efforts lie behind work to cure and prevent life threatening human mycoses, to control mycotoxins contaminations, and to counteract fungal spoilage of materials and “sick-building” syndrome.

 

 

Saccharomyces cerevisiae var. boulardii As an Eukaryotic Probiotic and Its Therapeutic Functions.

By Hadi Pourjafar, Negin Noori and Hassan Ghorbani-Choboghlo

 

This probiotic yeast was employed to be recognized as a split species as that of Saccharomyces cerevisiae, nevertheless, investigators have currently declared that S. boulardii is extremely like cerevisiae, consequently, it is a strain of cerevisiae. Conversely, the scientific name for it is Saccharomyces cerevisiae strain (or “variant” as it is sometimes identified) S.boulardii. However, S.boulardii is seen on the tags of manufactured goods (Büchl et al., 2010; Czerucka et al., 2007; Edwards-Ingram et al. A probiotic in terms of its advantageous outcomes, S.boulardii has various characteristics from the mainly fundamental to highly progressed. One of the major advantages of employing S.boulardii, particularly at the time of taking antibiotics, is that it is not influenced antibiotics because it contains yeast (Barc et al., 2008; Beaugerie and Petit, 2004; Can et al., 2006; Guslandi, 2010; Kotowska et al., 2005; McFarland, 2006; McFarland et al., 1995, McFarland et al., 1994; Szajewska and Mrukowicz, 2005). S.boulardii is a factual probiotic yeast superstar. For the past 30 years, doctors have suggested it to cure patients with diarrheal. It facilitate the adjustment of intestines and guards them from pathogens and other abnormalities in the intestinal lining. These days, S.boulardii is regularly marketed as a probiotic in a lyophilized shape and is so often referred to as S.bouladii lyo (Lukaszewicz).